This surveillance report was prepared by EUVAC.net, which is a European surveillance network for vaccine-preventable diseases. The network collects data on surveillance systems and selected epidemiological characteristics of vaccine preventable diseases in the EU and other participating countries. It is jointly funded by ECDC and the Statens Serum Institut (Denmark).
This guide presents the reader with a host of ideas on how to effectively communicate on all issues that relate to measles, mumps and rubella (MMR) vaccination.
Ebola viruses and Marburg virus are classified as biosafety level 4 (BSL-4) pathogens and require special containment and barrier protection measures, in particular for people taking care of infected patients or bodies.
2014 was the first year that Ebola viral haemorrhagic fever infections were notified in TESSy, prompted by an outbreak in West Africa. Several, mostly travel-related, cases were reported in Europe since. Latest data from the Annual epidemiological report